Arzeda Raises $33M Series B Led by Conti Ventures to Commercialize Computer-Designed Enzymes
Arzeda raised $33 million in a Series B led by Conti Ventures with participation from Lewis & Clark Agrifood, Bunge Ventures, Circulate Capital, and returning investors to accelerate commercialization of computer-designed enzymes for food, home care, chemicals, and other sectors.
No comments yet.